Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

02 Jun 2026 - 04 Jun 2026
17 Jun 2026 - 19 Jun 2026

Surgical Smoke Toxic Byproducts Could Harm Surgeons

By HospiMedica International staff writers
Posted on 17 Jun 2010
Surgical smoke, a common byproduct of procedures such as combined transurethral resection and vaporization of the prostate (CTURVP), contains toxic chemicals, including some explosive and harmful carcinogens, according to a new study.

Researchers from Chonbuk National University (Jeonbuk, Korea) and Wonkwang University (Iksan City, Korea) analyzed smoke samples from six CTURVP procedures. More...
A total of 12 smoke samples were collected from a continuous irrigation suction drainage system during surgery. The gases were quantitatively and qualitatively analyzed by a gas chromatography-mass spectrometry (GC-MS) system equipped with a purge and trap sample injector.

The researchers found that the main chemical constituents of surgical smokes produced in CTURVP are propylene, allene, isobutylene, 1,3-butadiene, vinylacetylene, mecaptomethane, ethylacetylene, diacetylene, 1-pentene, EtOH, piperylene, propenylacetylene,1,4-pentadiene, cyclopentadiene, acrylnitrile and butyrolacton. All of the chemical are considered toxic, and three of them are carcinogenic. Several of the chemicals can cause central nervous system depression and skin, eye, and respiratory irritation. The study was presented as a poster session at the European Association of Urology (EAU) annual meeting, held during April 2010 in Barcelona (Spain).

"Higher quality filter masks, smoke evacuation device, and/or smoke filter should be developed for safety for operating personnel and patients in CTURVP,” concluded lead author Yun Jo Chung, Ph. D., and colleagues.

"This is certainly an occupational hazard that urologists and operating room personnel working with urologists may be exposed to more often than they would like. Ascertaining the degree to which this exposure may contribute to any ill effects in those people who are exposed will require further study,” commented Anthony Smith, M.D., a spokesperson for the American urological Association (AUA).

Related Links:

Chonbuk National University
Wonkwang University



Gold Member
Neonatal Heel Incision Device
Tenderfoot
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Wound Irrigation Solution
Prontosan®
Immobilization System
Cranial 4Pi Immobilization
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Copyright © 2000-2026 Globetech Media. All rights reserved.